Effect of obesity on the pharmacokinetics of drugs in humans

MJ Hanley, DR Abernethy, DJ Greenblatt - Clinical pharmacokinetics, 2010 - Springer
The prevalence of obesity has dramatically increased in recent years and now includes a
significant proportion of the world's children, adolescents and adults. Obesity is linked to a …

Impact of obesity on drug metabolism and elimination in adults and children

MJE Brill, J Diepstraten, A van Rongen… - Clinical …, 2012 - Springer
The prevalence of obesity in adults and children is rapidly increasing across the world.
Several general (patho) physiological alterations associated with obesity have been …

[PDF][PDF] (2022)

T Zhang, EH Krekels, C Knibbe - … in the obese …, 2013 - scholarlypublications …
Introduction: Obesity is associated with many physiological changes. We review available
evidence regarding five commonly accepted assumptions to a priori predict the impact of …

Obesity in anaesthesia and intensive care

JP Adams, PG Murphy - British journal of anaesthesia, 2000 - academic.oup.com
The prevalence of significant obesity continues to rise in both developed and developing
countries, and is associated with an increased incidence of a wide spectrum of medical and …

Lean body mass as a predictor of drug dosage: implications for drug therapy

DJ Morgan, KM Bray - Clinical pharmacokinetics, 1994 - Springer
There is mounting evidence to suggest that lean body mass (LBM) may be a better predictor
of drug dosage than either total bodyweight (TBW) or body surface area (BSA), although the …

Remifentanil pharmacokinetics in obese versus lean patients

TD Egan, B Huizinga, SK Gupta… - The Journal of the …, 1998 - pubs.asahq.org
Background Remifentanil is a short-acting opioid whose pharmacokinetics have been
characterized in detail. However, the impact of obesity on remifentanil pharmacokinetics has …

Drug pharmacokinetics in the obese population: challenging common assumptions on predictors of obesity-related parameter changes

T Zhang, EHJ Krekels, C Smit… - Expert opinion on drug …, 2022 - Taylor & Francis
Introduction Obesity is associated with many physiological changes. We review available
evidence regarding five commonly accepted assumptions to a priori predict the impact of …

Pharmacokinetics of obese adults: Not only an increase in weight

J Gouju, S Legeay - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Obesity is a pathophysiological state defined by a body mass index> 30 kg/m 2 and
characterized by an adipose tissue accumulation leading to an important weight increased …

Effect of lipophilicity on drug distribution and elimination: influence of obesity

CD Bruno, JS Harmatz, SX Duan… - British Journal of …, 2021 - Wiley Online Library
Aims For a given passively‐distributed lipophilic drug, the extent of in vivo distribution
(pharmacokinetic volume of distribution, Vd) in obese individuals increases in relation to the …

Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs

M Dostalek, F Akhlaghi, M Puzanovova - Clinical pharmacokinetics, 2012 - Springer
The effects of diabetes mellitus on the pharmacokinetics and pharmacodynamics of drugs
have been well described in experimental animal models; however, only minimal data exist …